Vestaron Announces Series B-1 Financing
February 16, 2021
Vestaron, a company dedicated to improving the safety, efficacy and sustainability of crop protection through its development of peptide-based biopesticides, announces $18 million in Series B-1 financing, led by Northpond Ventures. Northpond and additional new investor, Cavallo Ventures, the venture arm of Wilbur-Ellis, join continuing investors Novo Holdings, Syngenta Ventures, CGC Ventures and Anterra Capital in this round. Adam Wieschhaus, Director at Northpond Ventures, will join the Vestaron Board of Directors.
With its proprietary platform for the optimization, production and delivery of peptide-based biopesticides, Vestaron is leading the development of a novel class of crop protection products – peptides (small proteins). These peptides have the proven modes of action and thus the same efficacy as traditional synthetics with the safety and environmental friendliness of biologics. These products provide an essential new tool for growers as some existing products face increasing regulatory pressure due to environmental concerns and others decline in their efficacy due to the development of resistance.
The Series B-1 financing was designed to accelerate Vestaron’s commercial development. The company’s lead insecticidal peptide, Spear®, completed its first year of full commercialization in 2020. Spear was launched both as Spear-Lep, targeting lepidopteran pests in specialty crops, and Spear-T, targeting soft-bodied insects such as thrips, whiteflies, aphids, mites and drosophila. Launch year sales were strong despite COVID headwinds, reaching 3% market share in California pistachios. This strong market traction was fueled both by Spear’s IRAC-validated novel mode of action and by its demonstrated efficacy on par with leading synthetics – including efficacy out to 30 days after application in a major study in almonds. Strong enthusiasm on the part of both Vestaron’s channel partners and major growers – including many expecting more than 10x year-over-year growth in usage – point to an acceleration for 2021.
This round was substantially over-subscribed, leaving the company well-capitalized heading into this year of commercial expansion throughout North America. Vestaron is excited to welcome both Northpond and Cavallo as new members of a deep and strong investor syndicate now supporting the company.